Hjem › Aterosklerose › Ohio
Aterosklerose kliniske forsøg i Ohio
8 studier for Aterosklerose søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research, Cleveland, Cleveland
- Centricity Research Columbus Ohio Multispecialty, Columbus
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Cleveland, Beachwood
- Aultman Hospital, Cardiovascular Consultants, Inc, Canton
- Velocity Clinical Research - Auburn, Cincinnati
- og 2 flere
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- The Christ Hospital, Cincinnati
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- HNC Dialysis, Ltd., Columbus
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Cincinnati
- Research Site, Columbus
- Research Site, Lima
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- NexGen Research, Lima
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.